Everett Stone

8.6k total citations · 2 hit papers
56 papers, 2.4k citations indexed

About

Everett Stone is a scholar working on Molecular Biology, Biotechnology and Biochemistry. According to data from OpenAlex, Everett Stone has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Biotechnology and 18 papers in Biochemistry. Recurrent topics in Everett Stone's work include Cancer Research and Treatments (21 papers), Amino Acid Enzymes and Metabolism (17 papers) and Virus-based gene therapy research (13 papers). Everett Stone is often cited by papers focused on Cancer Research and Treatments (21 papers), Amino Acid Enzymes and Metabolism (17 papers) and Virus-based gene therapy research (13 papers). Everett Stone collaborates with scholars based in United States, Poland and Lebanon. Everett Stone's co-authors include George Georgiou, Walter Fast, Scott W. Rowlinson, David L. Tierney, Lynne Chantranupong, Kendra Triplett, Candice Lamb, Achinto Saha, John DiGiovanni and Pei W. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Everett Stone

55 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth

2016 431 citations Achinto Saha, Jinyun Liu et al. Nature Medicine profile →
Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis

2020 248 citations Yun Pyo Kang, Chang Jiang et al. Cell Metabolism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Everett Stone	1.5k	766	693	411	368	56	2.4k
Macus Tien Kuo	1.9k 1.3×	1.1k 1.4×	320 0.5×	438 1.1×	150 0.4×	55	3.8k
Christiaan F. Labuschagne	2.2k 1.5×	1.4k 1.9×	354 0.5×	147 0.4×	308 0.8×	21	3.2k
Tomomi Fujii	1.2k 0.8×	437 0.6×	543 0.8×	108 0.3×	97 0.3×	182	2.7k
Young Hee Ko	3.7k 2.6×	2.0k 2.6×	360 0.5×	177 0.4×	185 0.5×	69	5.1k
S. R. McKeown	882 0.6×	952 1.2×	301 0.4×	182 0.4×	54 0.1×	26	1.9k
Ashley Solmonson	1.8k 1.2×	1.3k 1.7×	334 0.5×	93 0.2×	225 0.6×	18	2.8k
Jacinta Serpa	1.1k 0.7×	501 0.7×	257 0.4×	54 0.1×	242 0.7×	77	2.0k
Saroj P. Mathupala	2.6k 1.8×	2.1k 2.7×	177 0.3×	315 0.8×	99 0.3×	32	3.6k
Roberta Alfieri	2.1k 1.4×	648 0.8×	1.4k 2.0×	168 0.4×	102 0.3×	122	4.1k
Hubert Lincet	1.6k 1.1×	1.1k 1.5×	198 0.3×	92 0.2×	170 0.5×	35	2.3k

Countries citing papers authored by Everett Stone

Since Specialization

Citations

This map shows the geographic impact of Everett Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Everett Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Everett Stone more than expected).

Fields of papers citing papers by Everett Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Everett Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Everett Stone. The network helps show where Everett Stone may publish in the future.

Co-authorship network of co-authors of Everett Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Everett Stone. A scholar is included among the top collaborators of Everett Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Everett Stone. Everett Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saha, Achinto, Shengyuan Zhao, Rachel M. Clark, et al.. (2023). Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition. Journal of Experimental & Clinical Cancer Research. 42(1). 119–119. 15 indexed citations

Karamitros, Christos S., Candice Lamb, Everett Stone, et al.. (2022). Leveraging intrinsic flexibility to engineer enhanced enzyme catalytic activity. Proceedings of the National Academy of Sciences. 119(23). e2118979119–e2118979119. 26 indexed citations

Karamitros, Christos S., Yusuke Sugiyama, Yoichi Kumada, et al.. (2020). Conformational Dynamics Contribute to Substrate Selectivity and Catalysis in Human Kynureninase. ACS Chemical Biology. 15(12). 3159–3166. 6 indexed citations

Saha, Achinto, Shengyuan Zhao, Chen Zhao, et al.. (2020). Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer. Molecular Therapy. 29(2). 775–787. 15 indexed citations

Kang, Yun Pyo, Chang Jiang, Aimee Falzone, et al.. (2020). Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis. Cell Metabolism. 33(1). 174–189.e7. 248 indexed citations breakdown →

Cao, Jennifer Yinuo, Aunoy Poddar, Leslie Magtanong, et al.. (2019). A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity. Cell Reports. 26(6). 1544–1556.e8. 178 indexed citations

Saha, Achinto, et al.. (2019). Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth. npj Precision Oncology. 3(1). 16–16. 35 indexed citations

Thisted, Thomas, Céline Walmacq, Everett Stone, et al.. (2019). Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction. BMC Biotechnology. 19(1). 56–56. 18 indexed citations

Voss, Martin H., Arif Hussain, Nicholas J. Vogelzang, et al.. (2017). A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma. Annals of Oncology. 28(11). 2754–2760. 66 indexed citations

10.

Biswas, Pooja, Venkata Ramana Murthy Chavali, Everett Stone, et al.. (2016). A missense mutation inASRGL1is involved in causing autosomal recessive retinal degeneration. Human Molecular Genetics. 25(12). ddw113–ddw113. 12 indexed citations

11.

Saha, Achinto, Jinyun Liu, Surendar Tadi, et al.. (2016). Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nature Medicine. 23(1). 120–127. 431 indexed citations breakdown →

12.

Burrage, Lindsay C., Qin Sun, Sarah H. Elsea, et al.. (2015). Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. Human Molecular Genetics. 24(22). 6417–6427. 38 indexed citations

13.

Agrawal, Vaidehi, Jung Hee Woo, Jeremy Mauldin, et al.. (2014). In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts. Melanoma Research. 24(6). 556–567. 2 indexed citations

14.

Mauldin, Jeremy, Jung Hee Woo, Chan-Hee Jo, et al.. (2012). Recombinant Human Arginase Toxicity in Mice Is Reduced by Citrulline Supplementation. Translational Oncology. 5(1). 26–31. 30 indexed citations

15.

Romero, Philip A., Everett Stone, Candice Lamb, et al.. (2012). SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and Catalysis. ACS Synthetic Biology. 1(6). 221–228. 40 indexed citations

16.

Cantor, Jason R., et al.. (2011). Engineering Reduced-Immunogenicity Enzymes for Amino Acid Depletion Therapy in Cancer. Methods in enzymology on CD-ROM/Methods in enzymology. 502. 291–319. 42 indexed citations

17.

Agrawal, Vaidehi, et al.. (2011). Targeting methionine auxotrophy in cancer: discovery & exploration. Expert Opinion on Biological Therapy. 12(1). 53–61. 27 indexed citations

18.

Stone, Everett, et al.. (2011). Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy. Journal of Controlled Release. 158(1). 171–179. 21 indexed citations

19.

Linsky, Thomas W., A.F. Monzingo, Everett Stone, Jon D. Robertus, & Walter Fast. (2008). Promiscuous Partitioning of a Covalent Intermediate Common in the Pentein Superfamily. Chemistry & Biology. 15(5). 467–475. 7 indexed citations

20.

Thomas, Pei W., et al.. (2005). THE QUORUM-QUENCHING LACTONASE FROM BACILLUS THURINGIENSIS IS A METALLOPROTEIN. Macromolecules. 38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact